Angiomotin promotes breast cancer cell proliferation and invasion

Oncology Reports

Volumn 33, Issue 4, 2015, Pages 1938-1946

  Lv, Meng ^a   Lv, Meiling ^a   Chen, Ling ^a   Qin, Tianjie ^a   Zhang, Xiao ^a   Liu, Peijun ^a   Yang, Jin ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Angiomotin; Breast cancer; Hippo YAP; Invasion; Proliferation

Indexed keywords

ANGIOMOTIN; NUCLEOPROTEIN; ONCOPROTEIN; TRANSCRIPTION FACTOR YAP1; UNCLASSIFIED DRUG; AMOT PROTEIN, HUMAN; HIPPO PROTEIN, HUMAN; KI 67 ANTIGEN; LATS1 PROTEIN, HUMAN; MEMBRANE PROTEIN; PHOSPHOPROTEIN; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SMALL INTERFERING RNA; TAZ PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR PROTEIN; YAP1 (YES-ASSOCIATED) PROTEIN, HUMAN;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BREAST CANCER; CANCER CELL; CANCER STAGING; CELL INVASION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STUDENT T TEST; TISSUE REGENERATION; WESTERN BLOTTING; ADENOCARCINOMA; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; BREAST TUMOR; CELL DIVISION; DRUG SCREENING; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; RNA INTERFERENCE; TUMOR CELL LINE; TUMOR INVASION; WOUND HEALING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOCARCINOMA; BREAST NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KI-67 ANTIGEN; MEMBRANE PROTEINS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PHOSPHOPROTEINS; PROTEIN-SERINE-THREONINE KINASES; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR STEM CELL ASSAY; WOUND HEALING;

EID: 84924860073     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2015.3780     Document Type: Article

References (23)

1. Siegel R, Ma J, Zou Z and Jemal A: Cancer statistics, 2014. CA Cancer J Clin 64: 9-29, 2014.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
3. Berry DA, Cronin KA, Plevritis SK, et al: Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353: 1784-1792, 2005.
4. Fong PC, Boss DS, Yap TA, et al: Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med 361: 123-134, 2009.
5. Troyanovsky B, Levchenko T, Månsson G, Matvijenko O and Holmgren L: Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation. J Cell Biol 152: 1247-1254, 2001.
6. Patrie KM: Identification and characterization of a novel tight junction-associated family of proteins that interacts with a WW domain of MAGI-1. Biochim Biophys Acta 1745: 131-144, 2005.
7. Levchenko T, Aase K, Troyanovsky B, Bratt A and Holmgren L: Loss of responsiveness to chemotactic factors by deletion of the C-terminal protein interaction site of angiomotin. J Cell Sci 116: 3803-3810, 2003.
8. Ernkvist M, Aase K, Ukomadu C, et al: p130-Angiomotin associates to actin and controls endothelial cell shape. FEBS J 273: 2000-2011, 2006.
9. Bratt A, Birot O, Sinha I, et al: Angiomotin regulates endothelial cell-cell junctions and cell motility. J Biol Chem 280: 34859-34869, 2005.
10. Wells CD, Fawcett JP, Traweger A, et al: A Rich1/Amot complex regulates the Cdc42 GTPase and apical-polarity proteins in epithelial cells. Cell 125: 535-548, 2006.
11. Ernkvist M, Birot O, Sinha I, et al: Differential roles of p80-and p130-angiomotin in the switch between migration and stabilization of endothelial cells. Biochim Biophys Acta 1783: 429-437, 2008.
12. Ernkvist M, Luna Persson N, Audebert S, et al: The Amot/Patj/Syx signaling complex spatially controls RhoA GTPase activity in migrating endothelial cells. Blood 113: 244-253, 2009.
13. Zheng Y, Vertuani S, Nyström S, et al: Angiomotin-like protein 1 controls endothelial polarity and junction stability during sprouting angiogenesis. Circ Res 105: 260-270, 2009.
14. Jiang WG, Watkins G, Douglas-Jones A, Holmgren L and Mansel RE: Angiomotin and angiomotin like proteins, their expression and correlation with angiogenesis and clinical outcome in human breast cancer. BMC Cancer 6: 16, 2006.
15. Zhao B, Li L, Lu Q, et al: Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev 25: 51-63, 2011.
16. Levchenko T, Veitonmäki N, Lundkvist A, et al: Therapeutic antibodies targeting angiomotin inhibit angiogenesis in vivo. FASEB J 22: 880-889, 2008.
17. Ranahan WP, Han Z, Smith-Kinnaman W, et al: The adaptor protein AMOT promotes the proliferation of mammary epithelial cells via the prolonged activation of the extracellular signal-regulated kinases. Cancer Res 71: 2203-2211, 2011.
18. Chan SW, Lim CJ, Chong YF, Pobbati AV, Huang C and Hong W: Hippo pathway-independent restriction of TAZ and YAP by angiomotin. J Biol Chem 286: 7018-7026, 2011.
19. Wang W, Huang J and Chen J: Angiomotin-like proteins associate with and negatively regulate YAP1. J Biol Chem 286: 4364-4370, 2011.
20. Dai X, She P, Chi F, et al: Phosphorylation of angiomotin by Lats1/2 kinases inhibits F-actin binding, cell migration, and angiogenesis. J Biol Chem 288: 34041-34051, 2013.
21. Chan SW, Lim CJ, Guo F, Tan I, Leung T and Hong W: Actinbinding and cell proliferation activities of angiomotin family members are regulated by Hippo pathway-mediated phosphorylation. J Biol Chem 288: 37296-37307, 2013.
22. Hong W: Angiomotin'g YAP into the nucleus for cell proliferation and cancer development. Sci Signal 6: pe27, 2013.
23. Yi C, Shen Z, Stemmer-Rachamimov A, et al: The p130 isoform of angiomotin is required for Yap-mediated hepatic epithelial cell proliferation and tumorigenesis. Sci Signal 6: ra77, 2013.